Annual Total Liabilities
$35.88 M
-$508.00 K-1.40%
01 June 2022
Summary:
Pluristem Therapeutics annual total liabilities is currently $35.88 million, with the most recent change of -$508.00 thousand (-1.40%) on 01 June 2022. During the last 3 years, it has fallen by -$508.00 thousand (-1.40%).PSTI Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$32.85 M
-$3.03 M-8.43%
01 September 2022
Summary:
Pluristem Therapeutics quarterly total liabilities is currently $32.85 million, with the most recent change of -$3.03 million (-8.43%) on 01 September 2022.PSTI Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | -1.4% | -5.7% |
5 y5 years | +278.1% | +227.0% |
PSTI Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | -1.4% | -20.5% |
Pluristem Therapeutics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | $32.85 M(-8.4%) |
June 2022 | $35.88 M(-1.4%) | $35.88 M(-8.0%) |
Mar 2022 | - | $38.98 M(-5.7%) |
Dec 2021 | - | $41.34 M(+18.7%) |
Sept 2021 | - | $34.84 M(-4.3%) |
June 2021 | $36.39 M(+285.8%) | $36.39 M(+229.7%) |
Mar 2021 | - | $11.04 M(-0.7%) |
Dec 2020 | - | $11.12 M(+11.1%) |
Sept 2020 | - | $10.00 M(+6.1%) |
June 2020 | $9.43 M(-0.6%) | $9.43 M(+6.6%) |
Mar 2020 | - | $8.85 M(-1.1%) |
Dec 2019 | - | $8.95 M(-10.9%) |
Sept 2019 | - | $10.05 M(+5.9%) |
June 2019 | $9.49 M(-9.2%) | $9.49 M(-6.1%) |
Mar 2019 | - | $10.10 M(+10.9%) |
Dec 2018 | - | $9.11 M(-2.7%) |
Sept 2018 | - | $9.36 M(-10.4%) |
June 2018 | $10.45 M(+43.5%) | $10.45 M(+7.3%) |
Mar 2018 | - | $9.74 M(+25.4%) |
Dec 2017 | - | $7.77 M(+17.9%) |
Sept 2017 | - | $6.59 M(-9.5%) |
June 2017 | $7.28 M(-6.4%) | $7.28 M(-8.0%) |
Mar 2017 | - | $7.92 M(+10.2%) |
Dec 2016 | - | $7.18 M(-1.7%) |
Sept 2016 | - | $7.31 M(-6.2%) |
June 2016 | $7.79 M(-22.2%) | $7.79 M(+13.2%) |
Mar 2016 | - | $6.88 M(+2.8%) |
Dec 2015 | - | $6.69 M(-16.0%) |
Sept 2015 | - | $7.96 M(-20.5%) |
June 2015 | $10.01 M(-15.9%) | $10.01 M(+12.7%) |
Mar 2015 | - | $8.88 M(-3.5%) |
Dec 2014 | - | $9.20 M(-9.2%) |
Sept 2014 | - | $10.13 M(-14.8%) |
June 2014 | $11.90 M(+9.7%) | $11.90 M(+4.1%) |
Mar 2014 | - | $11.43 M(+8.9%) |
Dec 2013 | - | $10.49 M(-1.9%) |
Sept 2013 | - | $10.69 M(-1.5%) |
June 2013 | $10.85 M(+12.1%) | $10.85 M(+5.2%) |
Mar 2013 | - | $10.32 M(+2.4%) |
Dec 2012 | - | $10.08 M(+8.9%) |
Sept 2012 | - | $9.25 M(-4.4%) |
Date | Annual | Quarterly |
---|---|---|
June 2012 | $9.68 M(+273.1%) | $9.68 M(+7.6%) |
Mar 2012 | - | $8.99 M(-3.2%) |
Dec 2011 | - | $9.29 M(-2.7%) |
Sept 2011 | - | $9.55 M(+268.2%) |
June 2011 | $2.59 M(+58.1%) | $2.59 M(+7.7%) |
Mar 2011 | - | $2.41 M(+26.8%) |
Dec 2010 | - | $1.90 M(+16.3%) |
Sept 2010 | - | $1.63 M(-0.5%) |
June 2010 | $1.64 M(+53.5%) | $1.64 M(+12.6%) |
Mar 2010 | - | $1.46 M(+8.3%) |
Dec 2009 | - | $1.34 M(+18.3%) |
Sept 2009 | - | $1.14 M(+6.4%) |
June 2009 | $1.07 M(-14.8%) | $1.07 M(+26.5%) |
Mar 2009 | - | $845.00 K(-19.4%) |
Dec 2008 | - | $1.05 M(-0.1%) |
Sept 2008 | - | $1.05 M(-16.4%) |
June 2008 | $1.25 M(+51.3%) | $1.25 M(+9.3%) |
Mar 2008 | - | $1.15 M(+21.9%) |
Dec 2007 | - | $942.00 K(-3.0%) |
Sept 2007 | - | $971.00 K(+17.0%) |
June 2007 | $829.70 K(-79.6%) | $829.70 K(-70.2%) |
Mar 2007 | - | $2.78 M(+275.5%) |
Dec 2006 | - | $740.50 K(-76.1%) |
Sept 2006 | - | $3.10 M(-23.8%) |
June 2006 | $4.07 M(+398.1%) | $4.07 M(+514.5%) |
Mar 2006 | - | $662.20 K(+7.0%) |
Dec 2005 | - | $618.90 K(-0.5%) |
Sept 2005 | - | $621.90 K(-23.9%) |
June 2005 | $816.90 K(-19.9%) | $816.90 K(-59.3%) |
Mar 2005 | - | $2.01 M(+162.5%) |
Dec 2004 | - | $764.50 K(-6.0%) |
Sept 2004 | - | $813.20 K(-20.3%) |
June 2004 | $1.02 M(+102.3%) | $1.02 M(-46.2%) |
Mar 2004 | - | $1.90 M(+271.6%) |
Dec 2003 | - | $510.70 K(+1.7%) |
Sept 2003 | - | $502.30 K(-0.4%) |
June 2003 | $504.20 K(+448.6%) | $504.20 K(+1861.9%) |
Mar 2003 | - | $25.70 K(+37.4%) |
Dec 2002 | - | $18.70 K(-77.0%) |
Sept 2002 | - | $81.40 K(-11.4%) |
June 2002 | $91.90 K | $91.90 K |
FAQ
- What is Pluristem Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Pluristem Therapeutics?
What is Pluristem Therapeutics annual total liabilities?
The current annual total liabilities of PSTI is $35.88 M
What is the all time high annual total liabilities for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual total liabilities is $36.39 M
What is Pluristem Therapeutics quarterly total liabilities?
The current quarterly total liabilities of PSTI is $32.85 M
What is the all time high quarterly total liabilities for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly total liabilities is $41.34 M